Characterizing travel burden in oncology clinical trials: A single-institution analysis.
Overall, minority groups are underrepresented among long-distance enrollees, suggesting that those facing the greatest travel burden may never reach enrollment in the first place and underscore the need for targeted interventions aimed at improving clinical trial accessibility for underserved populations.